.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Dow
Fish and Richardson
Fuji
Queensland Health
Cerilliant
Argus Health
US Army
Novartis
Citi

Generated: September 24, 2017

DrugPatentWatch Database Preview

ZYFLO Drug Profile

« Back to Dashboard

What is the patent landscape for Zyflo, and what generic Zyflo alternatives are available?

Zyflo is a drug marketed by Chiesi Usa Inc and is included in two NDAs.

The generic ingredient in ZYFLO is zileuton. There are six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the zileuton profile page.

Summary for Tradename: ZYFLO

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list79
Clinical Trials: see list9
Patent Applications: see list3,615
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ZYFLO at DailyMed

Pharmacology for Tradename: ZYFLO

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chiesi Usa Inc
ZYFLO
zileuton
TABLET;ORAL020471-001Dec 9, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
Chiesi Usa Inc
ZYFLO
zileuton
TABLET;ORAL020471-003Dec 9, 1996RXYesYes► Subscribe► Subscribe► Subscribe
Chiesi Usa Inc
ZYFLO CR
zileuton
TABLET, EXTENDED RELEASE;ORAL022052-001May 30, 2007ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ZYFLO

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Chiesi Usa Inc
ZYFLO
zileuton
TABLET;ORAL020471-001Dec 9, 1996► Subscribe► Subscribe
Chiesi Usa Inc
ZYFLO
zileuton
TABLET;ORAL020471-003Dec 9, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Argus Health
McKinsey
Mallinckrodt
US Army
Teva
Farmers Insurance
Queensland Health
Chinese Patent Office
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot